Anti-CD20 antibody therapy for B-cell lymphomas

Daniel El Fassi, Laszlo Hegedüs, Claus Holstein Nielsen

Publikation: Bidrag til tidsskriftLetterForskning

OriginalsprogEngelsk
TidsskriftThe New England Journal of Medicine
Vol/bind367
Udgave nummer9
Sider (fra-til)876-878
ISSN0028-4793
DOI
StatusUdgivet - 2012

Citer dette

El Fassi, Daniel ; Hegedüs, Laszlo ; Nielsen, Claus Holstein. / Anti-CD20 antibody therapy for B-cell lymphomas. I: The New England Journal of Medicine. 2012 ; Bind 367, Nr. 9. s. 876-878.
@article{256fe8ebb52b40d3ad5e34f2dbdb8bb7,
title = "Anti-CD20 antibody therapy for B-cell lymphomas",
keywords = "Antibodies, Monoclonal, Murine-Derived, Antigens, CD20, Antineoplastic Agents, Humans, Lymphoma, B-Cell, Male",
author = "{El Fassi}, Daniel and Laszlo Heged{\"u}s and Nielsen, {Claus Holstein}",
year = "2012",
doi = "10.1056/NEJMc1207378#SA2",
language = "English",
volume = "367",
pages = "876--878",
journal = "The New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachusetts Medical Society",
number = "9",

}

Anti-CD20 antibody therapy for B-cell lymphomas. / El Fassi, Daniel; Hegedüs, Laszlo; Nielsen, Claus Holstein.

I: The New England Journal of Medicine, Bind 367, Nr. 9, 2012, s. 876-878.

Publikation: Bidrag til tidsskriftLetterForskning

TY - JOUR

T1 - Anti-CD20 antibody therapy for B-cell lymphomas

AU - El Fassi, Daniel

AU - Hegedüs, Laszlo

AU - Nielsen, Claus Holstein

PY - 2012

Y1 - 2012

KW - Antibodies, Monoclonal, Murine-Derived

KW - Antigens, CD20

KW - Antineoplastic Agents

KW - Humans

KW - Lymphoma, B-Cell

KW - Male

U2 - 10.1056/NEJMc1207378#SA2

DO - 10.1056/NEJMc1207378#SA2

M3 - Letter

VL - 367

SP - 876

EP - 878

JO - The New England Journal of Medicine

JF - The New England Journal of Medicine

SN - 0028-4793

IS - 9

ER -